Gabriel Brayan Gutiérrez-Peredo

Gabriel Brayan Gutiérrez-Peredo

Auto-generated profile, based on publicly available information

Gabriel Brayan Gutiérrez-Peredo

Universidade Federal da Bahia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2024 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
GGGabriel Brayan Gutiérrez-Peredo
Gabriel Brayan Gutiérrez-Peredo
IMIris Montaño-Castellon
Iris Montaño-Castellon
AGAndrea Jimena Gutiérrez-Peredo
Andrea Jimena Gutiérrez-Peredo
MLMarcelo Barreto Lopes
Marcelo Barreto Lopes
FTFernanda Pinheiro Martin Tapioca
Fernanda Pinheiro Martin Tapioca
ALAntônio Alberto Da Silva Lopes
Antônio Alberto Da Silva Lopes
The 24-h urine protein (24-hUP) excretion is the gold standard for evaluating proteinuria. This study aimed to evaluate the diagnostic efficacy of protein/creatinine ratio (PCR) for estimating 24-hUP at various levels of renal function and proteinuria levels. A cross-sectional study was conducted between December 2021 and December 2023 in Salvador, Bahia-Brazil, as an extension of previously published data from the TUNARI study. The study included 217 samples from 152 patients with various levels of renal function and proteinuria. PCR in isolated samples and 24-hUP were determined conventionally within a 24-h timeframe. Patients were classified into three groups according to the level of renal function (Group 1 = 10 to < 30 mL/min, Group 2 = 30–60 mL/min, and Group 3 = > 60 mL/min) and level of proteinuria (< 0.3 g/day, 0.3–3.5 g/day, and > 3.5 g/day). The data were analyzed using the Spearman correlation (rs), coefficient of determination (r2), Bland–Altman plots and receiver operating characteristic (ROC) curve. Likelihood ratios, positive (LR +), and negative (LR-) were derived from the sensitivity and specificity of PCR. Mean age was 41.5 ± 15.7 years, 61.8% were women, 36.8% Black and 52% Mixed-race. Glomerulopathies constituted 80.3%; 46.1% with lupus nephritis. Of the total urine samples, we observed a high correlation between PCR in the total sample of 24-hUP sample (rs = 0.86, p < 0.001) across different levels of renal function. However, agreement between PCR and 24-hUP was reduced at higher levels of proteinuria. The ROC analysis showed an AUC of 0.95 (95% CI = 0.92, 0.98), sensitivity of 91% and specificity of 86.5% (LR + 6.7; LR- 0.1), with an optimal cut-off of 0.77. These results were similar across renal function levels. Proteinuria ≤ 0.3 g/day showed a high sensitivity of 83.3% and specificity of 90%, with an area under (AUC) of 0.85 (95% CI = 0.71; 0.94). In the 24-hUP range > 0.3–3.5 g/day, the sensitivity was 64.1%, the specificity was 84.6%, and the AUC was 0.76 (95% CI = 0.67; 0.84), PCR detected all cases > 3.5 g/day. PCR is a suitable measure to be used as an indicator of 24-hUP at different levels of renal function, but may have limitations at higher levels of proteinuria. Analysis of PCR by proteinuria level found that agreement as well as sensitivity decreases at higher levels, but it maintains good specificity and is able to identify nephrotic range proteinuria.

2 December 2023 in Nephron
Verified
Journal Article
Closed access
PDF file
GGGabriel Brayan Gutiérrez-Peredo
Gabriel Brayan Gutiérrez-Peredo
MMMárcia Tereza Silva Martins
Márcia Tereza Silva Martins
FSFernanda Albuquerque da Silva
Fernanda Albuquerque da Silva
MLMarcelo Barreto Lopes
Marcelo Barreto Lopes
GLGildete Barreto Lopes
Gildete Barreto Lopes
ALAntônio Alberto Da Silva Lopes
Antônio Alberto Da Silva Lopes
Background: The existing data support the Chalder Fatigue Questionnaire (CFQ-11) as a valid instrument to assess fatigue in maintenance hemodialysis (MHD) patients. The objective of this work was to investigate whether self-reported fatigue can serve as an independent prognostic indicator for mortality in MHD patients. Methods: The data are from 233 adult patients enrolled in the cohort “The Prospective Study of the Prognosis of Chronic Hemodialysis Patients” (PROHEMO) developed in Salvador, BA, Brazil. The Brazilian version of the validated CFQ-11 was used to calculate self-reported fatigue. The CFQ-11 scores may range from 0 to 33; higher scores represent more fatigue. Fatigue categories were created based on proposed cut point: absence or mild degree if CFQ-11 scores <4 and moderate to severe if scores ≥4. Cox models were used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) of associations between fatigue and mortality with adjustments for sociodemographic factors, time on dialysis, education, economic class, hemoglobin concentration, diabetes, heart failure, depression, and other psychiatric disorders. Results: The mean age was 51.5 ± 2.5 years, 58% were male, and 30% were diabetic. Self-reported moderate to severe fatigue was reported by 71% of patients. The mortality rate was 8.6 cases/100 person-years. Patients with moderate to severe fatigue had a more than threefold mortality rate (HR = 3.07, 95% CI: 1.19, 7.93) compared to patients with absent or mild fatigue, after extensive adjustments for covariates. Conclusion: The study provides evidence that self-reported fatigue can help identify MHD patients at higher risk of earlier death.

9 July 2023 in The International Journal of Artificial Organs
Verified
Journal Article
Closed access
FSFernanda Albuquerque da Silva
Fernanda Albuquerque da Silva
MMMarcia Tereza Silva Martins
Marcia Tereza Silva Martins
GGGabriel Brayan Gutiérrez-Peredo
Gabriel Brayan Gutiérrez-Peredo
AKAngiolina Campos Kraychete
Angiolina Campos Kraychete
CPCarolina Cartaxo Penalva
Carolina Cartaxo Penalva
ALAntônio Alberto Da Silva Lopes
Antônio Alberto Da Silva Lopes
Background and objective: Some studies on maintenance hemodialysis (MHD) patients report a longer survival, albeit with poorer health-related quality of life (HRQoL), and more depression symptoms in women than in men. Whether these gender differences vary with age is uncertain. We tested the associations of gender with mortality, depression symptoms, and HRQoL in MHD patients of different age groups. Methods: We used data from 1504 adult MHD patients enrolled in the PROHEMO, a prospective cohort in Salvador, Brazil. The KDQOL-SF was used for the component summaries of the mental (MCS) and physical (PCS) HRQoL scales. Depression symptoms were assessed by the complete version of the Center for Epidemiological Studies Depression Screening Index (CES-D). To test for gender differences, extensively adjusted linear models were used for depression and HRQoL scores, and Cox models for death hazard ratio (HR). Results: Women reported worse HRQoL than men, particularly for ages ⩾60 years. In the age group ⩾60 years, the adjusted difference (AD) in score was −3.45; 95% CI: −6.81, −0.70 for MCS −3.16; −5.72, −0.60 for PCS. Older (⩾60 years) women also had more depression symptoms (AD 4.98; 2.33, 7.64). Mortality was slightly lower in women than in men with an adjusted HR of 0.89 (0.71, 1.11) and consistent across age categories. Conclusions: In a sample of Brazilian MHD patients, women had a slightly lower mortality, albeit with more depression symptoms and poorer HRQoL than men, particularly among older patients. This study highlights the need to investigate gender inequalities for MHD patients across different cultures and populations.

29 April 2021 in AIDS Research and Human Retroviruses
Verified
Journal Article
Closed access
IMIris Montaño-Castellon
Iris Montaño-Castellon
DZDiana Zeballos
Diana Zeballos
GGGabriel Gutiérrez-Peredo
Gabriel Gutiérrez-Peredo
ENEduardo Martins Netto
Eduardo Martins Netto
Carlos BritesCarlos Brites
Carlos Brites
Frailty is associated with an increased probability of serious adverse health outcomes in the geriatric general population. People living with HIV have a higher prevalence of frailty. However, the magnitude of this problem in younger patients in South America is unknown. We aimed to determine the prevalence and factors associated with frailty. This is a cross-sectional study from the Brazilian cohort HIV-AIDS (CoBRA) developed between March and November of 2018, on patients ≥18 years of age. Frailty phenotype was assessed by original Fried criteria. The results were analyzed using descriptive statistics, while identification of factors related to frailty was assessed by using multivariate logistic regression. We enrolled 231 patients; all, but 2 were on antiretroviral therapy (ART). Median age was 45.6 interquartile range (36.7–52.1) years, 136 (58.9%) were male, and 86.7% self-identified as non-white. Mean CD4 count was 660 (±345) cells/mm 3 and 83.5% had undetectable HIV plasma viral load (<50 copies/mL). Prevalence of frailty and prefrailty was 10.4% and 52.4%, respectively. A CD4 count <200 cells/mm 3 , depression, low income, and use of third-line ART were variables significantly associated with a greater risk to present frail or prefrail status. Frailty prevalence increases with age and is an important health problem to health care in HIV aging patients. It requires proper strategies to its early detection, prevention, and management.

1 June 2024 in The International Journal of Artificial Organs
Verified
Journal Article
Closed access
GGGabriel Brayan Gutiérrez-Peredo
Gabriel Brayan Gutiérrez-Peredo
MMMárcia Tereza Silva Martins
Márcia Tereza Silva Martins
FSFernanda Albuquerque da Silva
Fernanda Albuquerque da Silva
MLMarcelo Barreto Lopes
Marcelo Barreto Lopes
GLGildete Barreto Lopes
Gildete Barreto Lopes
ALAntonio Alberto Lopes
Antonio Alberto Lopes
Background/objective: A high prevalence of fatigue and a positive association between fatigue and post-hemodialysis recovery have been reported in predominantly white populations of maintenance hemodialysis (MHD) patients. The present study evaluates associations between self-reported fatigue by the 11-item Chalder Fatigue Questionnaire (CFQ-11) and the need for post-hemodialysis recovery in a predominantly African-descent MHD population. Methods: A total of 233 patients (94% Black or Mixed-Race) participating in the “Prospective Study of the Prognosis of Patients on Maintenance Hemodialysis” (PROHEMO), Salvador, Brazil were recruited for this cross-sectional study. The CFQ-11 was used to measure fatigue: <4 for absent or mild, ⩾4 for moderate to severe. Patients were also asked if they needed some time to recover after the hemodialysis. Logistic regression was used to estimate odds ratio (OR) of the association with adjustments for age, sex, race, educational level, economic class level, diabetes, hearth failure, and hemoglobin. Results: Mean age was 51.5 ± 12.5 years. Moderate to severe fatigue (⩾4 points) was observed in 70.8% (165/233), and absent or mild fatigue (<4 points) in 29.2% (68/233). Compared to patients with fatigue scores <4 (20.6%), the need for post-hemodialysis recovery was 2.5 times greater in patients with fatigue scores ⩾4 (52.7%). The covariate-adjusted logistic regression OR was 4.60, 95% CI: 2.27, 9.21. Conclusion: This study in MHD patients of predominantly African descent supports self-reported fatigue assessed by the CFQ-11 as a relevant predictor of the need for post-hemodialysis recovery. The results offer a rationale for investigating whether interventions to prevent fatigue reduce the need of post-hemodialysis recovery.

24 June 2023 in Nephron
Verified
Journal Article
Closed access
PDF file
GGGabriel Brayan Gutiérrez-Peredo
Gabriel Brayan Gutiérrez-Peredo
IMIris Montaño-Castellón
Iris Montaño-Castellón
AGAndrea Jimena Gutiérrez-Peredo
Andrea Jimena Gutiérrez-Peredo
JTJuan P Aguilar Ticona
Juan P Aguilar Ticona
FMFabio Montaño-Castellón
Fabio Montaño-Castellón
AAAntonio Raimundo Pinto Almeida
Antonio Raimundo Pinto Almeida
Background: Lupus nephritis (LN) occurs in approximately 50% of people with systemic lupus erythematosus (SLE). The 24-h proteinuria (gold standard) is measured among other tests for the control and monitoring of LN activity. This study investigates the use of the protein/creatinine ratio (PCR) as an alternative for the detection of proteinuria and its accuracy compared to the gold standard in a predominantly non-white population. Methods: This was a prospective study conducted in Salvador, Brazil, between December 2021 and May 2022. We invited adult patients diagnosed with SLE and LN, regardless of their disease activity. The estimation of the PCR and 24-h proteinuria was performed using conventional methods. The analysis used was Spearman’s r correlation coefficient (rs), coefficient of determination (r2), and concordance by the Bland-Altman method. A specific sensitivity was measured by the ROC curve with its respective cut-off by the Youden Index. Results: We compared 112 samples of 75 patients with LN, with a mean age of 34.5 ± 11.8 years. Of these patients, 85% were women, 87.9% were non-white. A high degree of correlation was observed between PCR with 24-h proteinuria (rs = 0.77 and r2 = 0.59). The ROC analysis shows an area under the curve of 0.92 and the cut-off point calculated by the Youden Index was 0.78 with a sensitivity of 90.0% and specificity of 82%. However, the Bland-Altman graph indicated decreasing concordance as the degree of proteinuria increased, despite showing concordance at high levels of proteinuria. Conclusion: The PCR shows high sensitivity to follow-up patients with LN when compared with 24-h proteinuria. Our findings suggest that PCR is a useful parameter for the evaluating and monitoring patients in complete remission. However, in cases of partial remission, the utility of PCR is limited.